Skip to content
Clinical Trials – home

General Hospital Of Chania Agios Georgios

Research site

Greece Agiou Eleftheriou 28, 733 00 Chania, Greece

  • 1 trial recruiting
  • Obesity · Arteriosclerosis · Overweight
  • Adult patients

About Specializations

General Hospital Of Chania Agios Georgios in Chania, Greece specialises in clinical trials of conditions such as Obesity, Arteriosclerosis, Overweight, Systemic candida, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Research

The medical center is at the forefront of cardiovascular research, focusing on innovative approaches to prevent and manage heart-related conditions. The center's work is pivotal in understanding the complexities of heart failure and cardiovascular mortality.

  • Heart Failure Prevention
  • Cardiovascular Mortality Reduction

Through its research, the center is contributing significantly to the development of new therapeutic strategies that aim to improve patient outcomes and quality of life for those at risk of heart failure.

Infectious Disease Research

Specializing in infectious diseases, the medical center is dedicated to advancing the treatment of complex infections such as candidemia. The research conducted here is crucial in enhancing the efficacy and safety of adjunctive therapies.

  • Candidemia Treatment
  • Adjunctive Therapy Efficacy

The center's efforts are instrumental in developing comprehensive treatment protocols that address both the infection and associated mortality risks, thereby setting new standards in infectious disease management.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Agiou Eleftheriou 28733 00 ChaniaGreece
Recruiting now
1 trial
Conditions studied
4

More sites in ChaniaGreece

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

3 clinical trials

Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Obesity+2

Not yet recruiting

Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease

Investigational
Countries:GreeceGreece
  • Participants:18–64 years
  • Sponsor:Novo Nordisk A/S

Systemic candida

Not recruiting

Study of Recombinant Interferon-Gamma 1b Combined with Standard Treatment for Patients with Candidemia: Safety and Effectiveness Evaluation

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Recombinant human interferon gamma 1B
  • Sponsor:Stichting Radboud universitair medisch centrum
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.